National Planning Corp raised its position in shares of Intrexon Corporation (NYSE:XON) by 13.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,958 shares of the biotechnology company’s stock after buying an additional 1,528 shares during the period. National Planning Corp’s holdings in Intrexon Corporation were worth $316,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the stock. Pacer Advisors Inc. increased its position in shares of Intrexon Corporation by 21.6% in the first quarter. Pacer Advisors Inc. now owns 7,352 shares of the biotechnology company’s stock worth $146,000 after buying an additional 1,305 shares in the last quarter. SG Americas Securities LLC acquired a new position in shares of Intrexon Corporation during the first quarter worth approximately $164,000. Cullinan Associates Inc. acquired a new position in shares of Intrexon Corporation during the second quarter worth approximately $201,000. Biondo Investment Advisors LLC acquired a new position in shares of Intrexon Corporation during the first quarter worth approximately $214,000. Finally, John G Ullman & Associates Inc. acquired a new position in shares of Intrexon Corporation during the second quarter worth approximately $212,000. Institutional investors own 84.52% of the company’s stock.

Shares of Intrexon Corporation (NYSE XON) opened at 18.55 on Tuesday. The company has a 50-day moving average price of $22.73 and a 200 day moving average price of $21.94. Intrexon Corporation has a 52 week low of $17.70 and a 52 week high of $32.90. The stock’s market capitalization is $2.24 billion.

Intrexon Corporation (NYSE:XON) last announced its quarterly earnings results on Wednesday, August 9th. The biotechnology company reported ($0.16) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.21) by $0.05. Intrexon Corporation had a negative return on equity of 19.04% and a negative net margin of 60.63%. The business had revenue of $54.40 million for the quarter, compared to the consensus estimate of $57.17 million. During the same period last year, the business posted ($0.42) EPS. The business’s revenue was up 3.6% compared to the same quarter last year. Equities analysts forecast that Intrexon Corporation will post ($0.87) EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by Watch List News and is owned by of Watch List News. If you are viewing this piece on another website, it was stolen and republished in violation of United States and international trademark and copyright law. The legal version of this piece can be accessed at https://www.watchlistnews.com/intrexon-corporation-xon-position-increased-by-national-planning-corp/1489379.html.

A number of brokerages recently commented on XON. Northland Securities set a $30.00 target price on Intrexon Corporation and gave the company a “buy” rating in a report on Monday, August 7th. BidaskClub downgraded Intrexon Corporation from a “hold” rating to a “sell” rating in a report on Friday, August 4th. Finally, Zacks Investment Research downgraded Intrexon Corporation from a “hold” rating to a “sell” rating in a report on Thursday, July 13th. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating to the company’s stock. Intrexon Corporation presently has an average rating of “Hold” and a consensus target price of $40.50.

In related news, CEO Randal J. Kirk purchased 132,625 shares of the business’s stock in a transaction dated Friday, August 11th. The shares were acquired at an average cost of $18.85 per share, for a total transaction of $2,499,981.25. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Dean J. Mitchell purchased 5,000 shares of the business’s stock in a transaction dated Friday, August 11th. The stock was bought at an average price of $18.33 per share, for a total transaction of $91,650.00. Following the completion of the acquisition, the director now directly owns 18,103 shares in the company, valued at approximately $331,827.99. The disclosure for this purchase can be found here. Insiders bought a total of 139,719 shares of company stock worth $2,629,574 over the last quarter. Company insiders own 56.30% of the company’s stock.

About Intrexon Corporation

Intrexon Corporation (Intrexon) forms collaborations to create biologically-based products and processes using synthetic biology. The Company’s domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Belgium and Hungary. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components.

Want to see what other hedge funds are holding XON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intrexon Corporation (NYSE:XON).

Institutional Ownership by Quarter for Intrexon Corporation (NYSE:XON)

Receive News & Ratings for Intrexon Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intrexon Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.